Over the past two decades, the Polish CRO industry has transformed dramatically. What began with simple monitoring tasks has evolved into comprehensive offerings, covering full-process management, data analysis, and early-phase trials.
Today, the value of clinical trials in Poland stands at approximately €1.5 billion, contributing to an overall European market of around €12 billion, which is growing steadily at a rate of 5–6% year-on-year.
Thanks to private investments and robust scientific infrastructure, Poland and the CEE region have established a compelling position in global clinical research. Their emergence is a story of rapid evolution—from a supportive environment into a true innovation hub.
Marcel Zatoński (Puls Biznesu) helped highlight this transformation in a recent article. Don’t miss the full story: read the piece here (in Polish).
A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…
The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.…
What Are Nuclear Medicine Procedures and How Are They Used in Clinical Trials? Nuclear medicine procedures (NMPs) are diagnostic and/or…
Copyright @ 2025 Axcellant